Boston Scientific ... rhythm and heart failure products that generated sales of nearly $1.6 billion in the quarter. After its successful PFA launch, Boston Scientific is embarking on initiatives ...

The adjustment comes as BTIG analysts project a significant rise in U.S. revenue from Farapulse, a Boston Scientific product, by 2025. The analysts at BTIG have revised their revenue forecast for ...

Beyond technological innovations and effectiveness, a key factor is its cost-reduction approach to its products, enabling greater adoption by the medical community. Boston Scientific has performed ...

Boston Scientific acquires Bolt Medical for $443 million upfront, with up to $221 million contingent on regulatory milestones. Bolt IVL platform uses acoustic waves to treat calcified artery ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

But there’s a powerful fundamental story happening with Boston Scientific. Also, EPS is estimated to ramp higher this year by +13.8%. Now it makes sense why the stock has been powering to new ...

The Marlborough device maker is paying $443 million upfront, plus up to $221 million in possible milestones, to buy the remainder of a company in which it already owned a major stake. Boston ...